Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?

doi:10.4252/wjsc.v6.i4.441

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8054)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

446

WORD

279

HTML

3182

Figures (1-1)

124

Tables (1-1)

124

Sum=4155

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

622

Download

794

Sum=1416

Publishing Process of This Article

Item

Count

Browse

1165

Download

1318

Sum=2483

Sep 26, 2014 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (44)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Sep 26, 2014; 6(4): 441-447
Published online Sep 26, 2014. doi: 10.4252/wjsc.v6.i4.441

Open in New Tab Full Size Figure Download Figure

Figure 1 Death of bulk cancer cells by chemotherapy, but not cancer stem cells leads to recurrence.

Citation: Haygood CLW, Arend RC, Straughn JM, Buchsbaum DJ. Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival? World J Stem Cells 2014; 6(4): 441-447
URL: https://www.wjgnet.com/1948-0210/full/v6/i4/441.htm
DOI: https://dx.doi.org/10.4252/wjsc.v6.i4.441